Your browser doesn't support javascript.
loading
Cardiovascular risk prediction using physical performance measures in COPD: results from a multicentre observational study.
Fermont, Jilles M; Fisk, Marie; Bolton, Charlotte E; MacNee, William; Cockcroft, John R; Fuld, Jonathan; Cheriyan, Joseph; Mohan, Divya; Mäki-Petäjä, Kaisa M; Al-Hadithi, Ali B; Tal-Singer, Ruth; Müllerova, Hana; Polkey, Michael I; Wood, Angela M; McEniery, Carmel M; Wilkinson, Ian B.
Afiliación
  • Fermont JM; Division of Experimental Medicine and Immunotherapeutics, Department of Medicine, University of Cambridge, Cambridge, UK jmf88@medschl.cam.ac.uk.
  • Fisk M; British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Bolton CE; Division of Experimental Medicine and Immunotherapeutics, Department of Medicine, University of Cambridge, Cambridge, UK.
  • MacNee W; Division of Respiratory Medicine and NIHR Nottingham BRC respiratory theme, University of Nottingham, Nottingham, UK.
  • Cockcroft JR; Centre for Inflammation Research, Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, UK.
  • Fuld J; Department of Cardiology, Columbia University Medical Center, New York City, New York, USA.
  • Cheriyan J; Department of Respiratory Medicine, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Mohan D; Division of Experimental Medicine and Immunotherapeutics, Department of Medicine, University of Cambridge, Cambridge, UK.
  • Mäki-Petäjä KM; Medical Innovation, Value Evidence Outcomes, GSK R&D, Philadelphia, Pennsylvania, USA.
  • Al-Hadithi AB; Division of Experimental Medicine and Immunotherapeutics, Department of Medicine, University of Cambridge, Cambridge, UK.
  • Tal-Singer R; Division of Experimental Medicine and Immunotherapeutics, Department of Medicine, University of Cambridge, Cambridge, UK.
  • Müllerova H; Medical Innovation, Value Evidence Outcomes, GSK R&D, Philadelphia, Pennsylvania, USA.
  • Polkey MI; GSK R&D, Uxbridge, UK.
  • Wood AM; Department of Respiratory Medicine, Royal Brompton Hospital, London, UK.
  • McEniery CM; British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Wilkinson IB; British Heart Foundation Centre of Research Excellence, University of Cambridge, Cambridge, UK.
BMJ Open ; 10(12): e038360, 2020 12 28.
Article en En | MEDLINE | ID: mdl-33372069
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / Enfermedad Pulmonar Obstructiva Crónica Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: BMJ Open Año: 2020 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / Enfermedad Pulmonar Obstructiva Crónica Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: BMJ Open Año: 2020 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Reino Unido